Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657553 · ClinicalTrials.gov registry record · Phase 3
Preemptive Strike With Bortezomib in Multiple Myeloma Patients
A Phase 3 study, sponsored by University of Arkansas.
- Terminated
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT00657553: Clinical Trial Phase 3 study, sponsored by University of Arkansas.
NCT00657553 is a Phase 3 study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 10 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00657553, a Phase 3 study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
To evaluate whether using the drug bortezomib at the start of remission will prevent relapse for a longer period of time.
Primary Outcome
The number of patients on Bortezomib that have maintained event-free survival, compared to the patients on observation was not analyzed due to low attrition rates. Event-free survival is a measure of the proportion of people who remain free of a particular complication of disease (called an event) after treatment that is designed to prevent or delay that particular complication.
Interventions
- DRUG Bortezomib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Why NCT00657553 stopped before completion
NCT00657553 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Bortezomib is the first listed.
NCT00657553 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00657553 about?
NCT00657553 is a clinical study titled "Preemptive Strike With Bortezomib in Multiple Myeloma Patients". To evaluate whether using the drug bortezomib at the start of remission will prevent relapse for a longer period of time.
What is the current status of trial NCT00657553?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2008-02. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00657553?
The interventions under investigation include: Bortezomib (DRUG).
Who is sponsoring clinical trial NCT00657553?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00657553's enrollment target sits among peer trials
10 1989th of 2000 higher than 9 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia